Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128309 · ClinicalTrials.gov registry record · NA
Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain
A NA study of Generalized Anxiety Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT01128309 is a NA study of Generalized Anxiety Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 29 participants, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01128309, a NA study of Generalized Anxiety Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.
Conditions Studied
Interventions
- BEHAVIORAL Stress Reduction Intervention
- BEHAVIORAL Active Control intervention
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01128309
The ClinicalTrials.gov registry entry for NCT01128309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (86% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Stress Reduction Intervention is the first listed.
NCT01128309 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01128309 about?
NCT01128309 is a clinical study titled "Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain". The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.
What is the current status of trial NCT01128309?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2010-05. Estimated completion is 2011-04.
What conditions does trial NCT01128309 study?
This clinical trial studies the following conditions: Generalized Anxiety Disorder.
What interventions are being tested in trial NCT01128309?
The interventions under investigation include: Stress Reduction Intervention (BEHAVIORAL), Active Control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01128309?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01128309 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Generalized Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
RECRUITING · NA
-
Massage for GAD: Neuroimaging and Clinical Correlates of Response
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.